BCL2L1 and cancer: Taken together, these findings reveal that alternative splicing of the apoptotic Bcl-x pre-mRNA may be altered during the induction of cardiomyocyte apoptosis in heart failure as well as during cardio-toxicity induced by some anti-cancer drugs.